1-181049076-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBS2_Supporting
The NM_001385161.1(MR1):c.92G>A(p.Arg31His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0106 in 1,613,946 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001385161.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MR1 | NM_001385161.1 | c.92G>A | p.Arg31His | missense_variant | 2/6 | ENST00000367580.6 | NP_001372090.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MR1 | ENST00000367580.6 | c.92G>A | p.Arg31His | missense_variant | 2/6 | 1 | NM_001385161.1 | ENSP00000356552.5 |
Frequencies
GnomAD3 genomes AF: 0.00740 AC: 1126AN: 152206Hom.: 9 Cov.: 33
GnomAD3 exomes AF: 0.00750 AC: 1882AN: 250934Hom.: 14 AF XY: 0.00741 AC XY: 1005AN XY: 135616
GnomAD4 exome AF: 0.0110 AC: 16010AN: 1461622Hom.: 110 Cov.: 31 AF XY: 0.0107 AC XY: 7780AN XY: 727128
GnomAD4 genome AF: 0.00740 AC: 1127AN: 152324Hom.: 9 Cov.: 33 AF XY: 0.00706 AC XY: 526AN XY: 74484
ClinVar
Submissions by phenotype
Immunodeficiency Pathogenic:1
Pathogenic, no assertion criteria provided | in vitro;research | Rossjohn lab, Monash University | - | The R31H variant in MR1 has been reported in 1 family with autosomal recessive inheritance of mild primary immunodeficiency characterised by persistent HPV warts as well as difficult to treat bacterial and viral infections. Protein structure and function studies of this variant shows disruption of antigen binding, preventing antigen presentation via MR1. This disrupts the development/maintenance of mucosal-associated invariant T (MAIT) cells. Thus we consider this variant is pathogenic but requires characterisation of more individuals with this variant to confirm penetrance of clinical symptoms. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | MR1: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at